Keele, UK, 13th September 2016 / Sciad Newswire / Prokarium today announced the start of its programme to develop an oral vaccine against Zika virus infection.
Tue, 13/09/2016 - 07:30
Mon, 12/09/2016 - 12:45
London, UK, 12th September 2016 – The RSA Group, the world's largest Talent Consultancy in Life Sciences, has announced the appointment of a new CEO, Alex Bennett.
Mon, 12/09/2016 - 11:15
London, UK, 12th September 2016 / Sciad Newswire / NALIA Systems is pleased to announce the filing of two new patent applications that highlight the co
Mon, 12/09/2016 - 09:30
Saffron Walden, UK, 12th September 2016 / Sciad Newswire / Established in 2001, Domainex is a privately-owned, rapidly-growing drug research company with expertis
Tue, 16/08/2016 - 09:00
Cambridge Research Biochemicals announces the release of its new Discovery Peptides® catalogue.
Thu, 11/08/2016 - 13:00
SynbiCITE and Rainbow Seed Fund announce the launch of Bio-Start, an annual competition to support early stage companies in the field of synthetic biology.
Wed, 03/08/2016 - 10:30
Abingdon, UK, 3rd August 2016 / Sciad Newswire / OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies, today announces the
Thu, 28/07/2016 - 14:00
San Francisco, CA, USA, 28th July 2016 / Sciad Newswire / SynBioBeta announced today they will again be bringing together the syntheti
Mon, 25/07/2016 - 08:00
Prokarium announces funding from UK & Mexican Governments to develop vaccines against Zika, bacterial diarrhoea and Plague.
Wed, 13/07/2016 - 15:00
Cypralis, a life sciences company focussed on the discovery of novel therapeutics based on modulation of peptidyl-prolyl isomerases (PPIases) has acquired a portfolio of cyclophilin inhibitor assets from SCYNEXIS Inc, a NASDAQ-listed company headquartered in New Jersey, USA.